Comparing to healthy hips, the femoral nerve in affected hips moved away from the femur while it got closer to anterior acetabular wall. The distances from the sciatic nerve to posterior acetabular wall and femur in affected hips were larger than those in healthy hips.
Understanding the anatomic adjacency of sciatic and femoral nerves in hip region could help reduce nerve injury during THA[17–19]. Previous studies on peripheral nerve anatomy and course were mainly based on magnetic resonance imaging (MRI) or cadaveric specimens. However, CT might be a better choice of evaluating nerve course for DDH[20–25]. On the one hand, MRI was not a routine examination for DDH patients and cannot clearly show bony landmarks; it would increase patients’ medical costs purely for the purpose of observing nerve course. On the other hand, it was very difficult to find cadaveric donors with DDH. Several researchers have confirmed that CT, as a routine preoperative examination for Crowe type IV DDH patients, can accurately identify sciatic and femoral nerve[21, 26, 27].
To date, there was only one study done in the subject of nerve course in patients with DDH. In 2015, Wang et al. [15] used CT to observe the nerve course in DDH patients and summarized the anatomical characteristics of sciatic nerve. They found that the sciatic nerve was located near the ischium and ilium but relatively far from the femur of the affected hip, compared to its location on the healthy hip for patients with unilateral DDH[15]. Their finding was important to help surgeons improve their understanding of soft tissue developmental abnormalities around the hip joint in patients with DDH, thereby reducing the risk of nerve injury. However, there were still some flaws in their study. Firstly, the study didn’t include Crowe type IV DDH, who was at the highest danger of nerve injury. Secondly, the reference section for all measurements were femur-based, and the femoral landmarks varied with the dislocation level, which reduced the comparability of bilateral nerves anatomical position. Thirdly, their measurement region excluded the area above acetabulum and the area below lesser trochanter, which were often the operating region for Crowe type IV DDH patients. Fourthly, only the sciatic nerve, but not the femoral nerve was analyzed.
The femoral nerve injury accounted for 27.78% (5/18) of all nerve injuries after surgery in Crowe type IV DDH[5]. However, previous studies reported that femoral nerve was more resistant to distraction than sciatic nerve; limb lengthening may not be the main cause of femoral nerve injury[11, 12]. Our findings provided a new explanation for femoral nerve injury in Crowe type IV DDH from the nerve course viewpoint. Firstly, the femoral nerve was only 1.3 cm on average away from the anterior acetabular wall, improperly positioned the retractor anterior to acetabulum, or prolonged traction may injure the femoral nerve. Secondly, overhanging acetabular cup was a common sacrifice for cup stability in Crowe type IV DDH hip replacement. The femoral nerve, originating from lumbar plexus, arced around anterior aspect of acetabulum into femoral triangle. When femoral nerve was stretched and tensed with less arc, nerve injury happened with touching the anterior edge of overhanging acetabular cup and cause.
Some studies have also confirmed that the placement of retractor anterior to acetabulum was a high-risk step of femoral nerve injury. Shubert et al.[26] investigated the position of acetabular retractor in relation to adjacent neurovascular structures in CT scans and cadavers. They found that the anterior inferior iliac spine is the safest anterior acetabular retractor position, with inferior progression along the anterior wall, the distance to the femoral neurovascular bundle decreases[26]. In our study, the distance between femoral nerve and anterior acetabular wall was smaller in Crowe type IV DDH compared to normally developed hip, which might increase the risk of intraoperative femoral nerve injury.
The advantages of this study are reflected in the following aspects. Firstly, only unilateral Crowe type IV DDH cases were included, eliminating the effect of factors such as body size on the data via an own-control design. Then, demographics such as sex, age, height, and weight were qualified, and previous history and neurological autoimmune diseases were excluded from interfering with the results. Finally, the pelvic bony landmarks were chosen as references suitable for all types of DDH and more clinically appropriate than the femur.
This study, however, also has several limitations. First, these criteria were very restrictive and excluded nearly 70% of Crowe IV DDH cases, making the sample size of this study relatively small. Second, the postoperative neurological complications of the cases were not studied, and it was not possible to correlate anatomical characteristic with clinical outcomes. So, we failed to evaluate the true impact of nerve coursing abnormalities on postoperative neurological function. Third, CT measurements in the supine position do not truly reflect the neurological status in the lateral position. Fourth, identifying the location of the nerve requires a relatively high CT resolution and personnel expertise, and sometimes requires repeated confirmation to increase the results’ consistency.